Literature DB >> 7046801

Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system.

M Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7046801     DOI： 10.1016/0304-419x(82)90010-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  7 in total

1.  Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?

Authors:  J S Teppema; E C de Boer; P A Steerenberg; A P van der Meijden
Journal:  Urol Res       Date:  1992

2.  Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis.

Authors:  E C de Boer; W H de Jong; A P van der Meijden; P A Steerenberg; F Witjes; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Urol Res       Date:  1991

3.  Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.

Authors:  W H de Jong; P A Steerenberg; J G Kreeftenberg; R H Tiesjema; W Kruizinga; L M van Noorle Jansen; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.

Authors:  W R Klein; P A Steerenberg; F Poelma; E vd Wiel; V P Rutten; W Misdorp; W H de Jong; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Characteristics of DTH suppressor cells in mice infected with Candida albicans.

Authors:  J C Valdez; O E Mesón; A Sirena; N G de Alderete
Journal:  Mycopathologia       Date:  1987-05       Impact factor: 2.574

6.  An anti-neoplastic glycan isolated from Mycobacterium bovis (BCG vaccine).

Authors:  R Wang; M E Klegerman; I Marsden; M Sinnott; M J Groves
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

Review 7.  Immunotherapy for bladder cancer.

Authors:  A M Kamat; D L Lamm
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.